Form 4: Evolent Health GC Reports Equity Transactions

Evolent Health's General Counsel, Jonathan Weinberg, reported a series of equity transactions including RSU vesting, PSU settlement, and a new PSU grant.

Summary

• Jonathan Weinberg, General Counsel of Evolent Health, Inc. (EVH), reported multiple equity transactions.
• On March 1, 2026, 4,406 shares of Class A Common Stock were disposed of at $3.25 to cover tax obligations from restricted stock unit (RSU) vesting.
• On March 2, 2026, 4,910 shares of Class A Common Stock were acquired at $0 upon the settlement of performance-based share units (PSUs) awarded on March 1, 2024, following the certification of performance metrics.
• Also on March 2, 2026, 1,896 shares of Class A Common Stock were disposed of at $3.58 to cover tax obligations from the settlement of performance-based share units.
• On March 3, 2026, an additional 8,275 shares of Class A Common Stock were disposed of at $3.51 to cover tax obligations from RSU vesting.
• A new grant of 179,661 performance-based share units (PSUs) was made on March 2, 2026, which may be earned based on stock price performance from March 1, 2027, to February 28, 2029, subject to service conditions.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive, reflecting the successful achievement of prior performance metrics leading to PSU settlement and the continued alignment of executive incentives with future stock price performance through a new PSU grant. The tax-related dispositions are routine.

Positives

• Settlement of 4,910 performance-based share units (PSUs) indicates the achievement of specified performance metrics by the company.
• A new grant of 179,661 performance-based share units (PSUs) aligns management incentives with future stock price performance.

Negatives

• A total of 14,577 shares of Class A Common Stock were disposed of across three transactions (4,406, 1,896, and 8,275 shares) to satisfy tax withholding obligations.

Future Outlook

The newly granted performance-based share units (PSUs) for Mr. Weinberg are tied to the achievement of certain stock price performance conditions between March 1, 2027, and February 28, 2029, indicating a future focus on stock value appreciation. The actual amount earned may range from 0% to 250% of the target level.

Industry Context

StockSavvy.ai notes that executive compensation tied to performance-based equity awards, such as PSUs, is a common practice across the healthcare technology sector. This structure aims to align executive incentives with long-term shareholder value creation, a trend observed as companies increasingly focus on sustainable growth and market performance.

Stakeholder Impact

• Shareholders: The new PSU grant aligns the General Counsel's interests with shareholder value creation through stock price performance targets.
• Employees: The compensation structure reflects standard executive incentive practices, potentially influencing broader compensation philosophies within the company.

Next Steps

• The newly granted performance-based share units (PSUs) will be subject to stock price performance conditions from March 1, 2027, to February 28, 2029.
• The actual amount of PSUs earned will be determined after the completion of the performance period, potentially ranging from 0% to 250% of the target level.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation events, including the vesting of equity awards and a new performance-based grant. While the new PSU grant aligns executive incentives with future stock performance, these transactions are generally expected and do not provide new fundamental information that would significantly alter the investment thesis for Evolent Health. Therefore, a 'hold' recommendation is appropriate, pending further operational or financial updates.

Keywords

Evolent Health, EVH, Form 4, Insider Trading, Jonathan Weinberg, General Counsel, Equity Transactions, Restricted Stock Units, Performance-Based Share Units, PSUs, RSUs, Stock Compensation, Executive Compensation